Being AI (BAI)

NZX-listed Healthcare company — share price, dividends, financials, board of directors and governance score.

Being AI (NZX:BAI) last traded at $0.003 on 21 Oct 2026, a market capitalisation of $1M NZD, a board of 4 directors chaired by Sean Joyce and a Governance Risk Score of 67/100.

Being AI (formerly Volpara Health Technologies) develops AI-powered medical imaging software to help detect breast cancer earlier through improved mammography analysis.

Share price
$0.003-25.00%
Market cap
$1MNZD
P/E ratio
0.7
Governance score
67/100Good
Board size
4directors
Last dividend
6.00cFY2025

Loading issuer details...

Being AI board of directors

4 current directors, average tenure 1.4 years.

DirectorRoleIndependentAppointedTenureCommittees
Sean JoyceChairNot recorded20260.0 yrs—
Steve PhillipsIndependent DirectorYes20251.6 yrsRemuneration Committee, Audit & Risk Committee (Chair)
Evan ChristianAlternate DirectorNo20242.6 yrsAudit & Risk Committee (Chair), Remuneration Committee (Chair)
Paul FornoExecutive DirectorNo20251.6 yrsRemuneration Committee (Chair), Audit & Risk Committee (Chair)

BAI governance score breakdown

Being AI scores 67/100 (Good) on the NZXplorer Governance Risk Score for FY2026, based on 68% data coverage. See the GRS methodology.

Board structure
9/25
Shareholder rights
15/15
Executive remuneration
5/10

BAI dividends

The most recent Being AI dividend on record is 6.00 cents per share, for FY2025 (interim).

Being AI largest shareholders

Top 10 registered holders of BAI as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.

#HolderHolding
12061 Limited Partnership67.78%
2Te Turanga Ukaipo Charitable Trust13.34%
32384 Limited Partnership10.67%
4Excalibur Capital Partners Limited5.13%
5Apz Limited0.73%
6New Zealand Depository Nominee Limited0.56%
7Jackson & Associates Limited0.21%
8Johannes Lodewikus Cilliers0.20%
9Arno Investments Limited0.16%
10Russell Graham Roberts0.10%

Recent BAI NZX announcements

The 10 most recent filings by Being AI to the NZX.

Being AI (BAI) — frequently asked questions

What does Being AI do?

Being AI (formerly Volpara Health Technologies) develops AI-powered medical imaging software to help detect breast cancer earlier through improved mammography analysis. Being AI is listed on the NZX under the ticker BAI, in the Healthcare sector.

What is the Being AI (BAI) share price?

Being AI (NZX:BAI) shares closed at $0.003 on 21 October 2026, down 25.00% on the previous close. At that price its market capitalisation was about $526,416, based on 175,472,000 shares on issue.

Who are the directors of Being AI?

Being AI has 4 current directors: Sean Joyce (Chair), Steve Phillips (Independent Director), Evan Christian (Alternate Director) and Paul Forno (Executive Director). Average board tenure is 1.4 years.

Who is the chair of Being AI?

Sean Joyce chairs the Being AI board, and has been a director since 2026.

What was Being AI's most recent dividend?

The most recent Being AI dividend on record is 6.00 cents per share for FY2025 (interim).

Who are the largest shareholders of Being AI?

The largest registered holder of BAI shares in the FY2025 top-20 register was 2061 Limited Partnership, with 67.78%, followed by Te Turanga Ukaipo Charitable Trust (13.34%) and 2384 Limited Partnership (10.67%).

What is Being AI's governance score?

Being AI has an NZXplorer Governance Risk Score of 67/100 (Good) for FY2026, based on 68% data coverage.

When was the last Being AI annual meeting?

The most recent Being AI annual meeting on record was held on 30 September 2026.

Healthcare companies on the NZX

Compare Being AI with other NZX-listed healthcare companies.

All NZX Healthcare companies · All NZX-listed companies